Yuanfan Ye

Yuanfan Ye

Auto-generated profile, based on publicly available information

Yuanfan Ye

Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2023 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
AMAmrita Mukherjee
Amrita Mukherjee
YYYuanfan Ye
Yuanfan Ye
HWHoward W. Wiener
Howard W. Wiener
MKMark H. Kuniholm
Mark H. Kuniholm
HMHoward Minkoff
Howard Minkoff
SSSadeep Shrestha
Sadeep Shrestha
Background: Cervical cancer oncogenesis starts with human papillomavirus (HPV) cell entry after binding to host cell surface receptors; however, the mechanism is not fully known. We examined polymorphisms in receptor genes hypothesized to be necessary for HPV cell entry and assessed their associations with clinical progression to precancer. Methods: African American women (N = 1,728) from the MACS/WIHS Combined Cohort Study were included. Two case–control study designs were used—cases with histology-based precancer (CIN3+) and controls without; and cases with cytology-based precancer [high-grade squamous intraepithelial lesions (HSIL)] and controls without. SNPs in candidate genes (SDC1, SDC2, SDC3, SDC4, GPC1, GPC2, GPC3, GPC4, GPC5, GPC6, and ITGA6) were genotyped using an Illumina Omni2.5-quad beadchip. Logistic regression was used to assess the associations in all participants and by HPV genotypes, after adjusting for age, human immunodeficiency virus serostatus, CD4 T cells, and three principal components for ancestry. Results: Minor alleles in SNPs rs77122854 (SDC3), rs73971695, rs79336862 (ITGA6), rs57528020, rs201337456, rs11987725 (SDC2), rs115880588, rs115738853, and rs9301825 (GPC5) were associated with increased odds of both CIN3+ and HSIL, whereas, rs35927186 (GPC5) was found to decrease the odds for both outcomes (P value ≤ 0.01). Among those infected with Alpha-9 HPV types, rs722377 (SDC3), rs16860468, rs2356798 (ITGA6), rs11987725 (SDC2), and rs3848051 (GPC5) were associated with increased odds of both precancer outcomes. Conclusions: Polymorphisms in genes that encode binding receptors for HPV cell entry may play a role in cervical precancer progression. Impact: Our findings are hypothesis generating and support further exploration of mechanisms of HPV entry genes that may help prevent progression to cervical precancer.

1 September 2023
Verified
Other
Open access
AMAmrita Mukherjee
Amrita Mukherjee
YYYuanfan Ye
Yuanfan Ye
HWHoward W. Wiener
Howard W. Wiener
MKMark H. Kuniholm
Mark H. Kuniholm
HMHoward Minkoff
Howard Minkoff
SSSadeep Shrestha
Sadeep Shrestha
Background:Cervical cancer oncogenesis starts with human papillomavirus (HPV) cell entry after binding to host cell surface receptors; however, the mechanism is not fully known. We examined polymorphisms in receptor genes hypothesized to be necessary for HPV cell entry and assessed their associations with clinical progression to precancer.Methods:African American women (N = 1,728) from the MACS/WIHS Combined Cohort Study were included. Two case–control study designs were used—cases with histology-based precancer (CIN3+) and controls without; and cases with cytology-based precancer [high-grade squamous intraepithelial lesions (HSIL)] and controls without. SNPs in candidate genes (SDC1, SDC2, SDC3, SDC4, GPC1, GPC2, GPC3, GPC4, GPC5, GPC6, and ITGA6) were genotyped using an Illumina Omni2.5-quad beadchip. Logistic regression was used to assess the associations in all participants and by HPV genotypes, after adjusting for age, human immunodeficiency virus serostatus, CD4 T cells, and three principal components for ancestry.Results:Minor alleles in SNPs rs77122854 (SDC3), rs73971695, rs79336862 (ITGA6), rs57528020, rs201337456, rs11987725 (SDC2), rs115880588, rs115738853, and rs9301825 (GPC5) were associated with increased odds of both CIN3+ and HSIL, whereas, rs35927186 (GPC5) was found to decrease the odds for both outcomes (P value ≤ 0.01). Among those infected with Alpha-9 HPV types, rs722377 (SDC3), rs16860468, rs2356798 (ITGA6), rs11987725 (SDC2), and rs3848051 (GPC5) were associated with increased odds of both precancer outcomes.Conclusions:Polymorphisms in genes that encode binding receptors for HPV cell entry may play a role in cervical precancer progression.Impact:Our findings are hypothesis generating and support further exploration of mechanisms of HPV entry genes that may help prevent progression to cervical precancer.

26 November 2025
Verified
Other
Open access
AMAmrita Mukherjee
Amrita Mukherjee
YYYuanfan Ye
Yuanfan Ye
HWHoward W. Wiener
Howard W. Wiener
MKMark H. Kuniholm
Mark H. Kuniholm
HMHoward Minkoff
Howard Minkoff
SSSadeep Shrestha
Sadeep Shrestha
Background:Cervical cancer oncogenesis starts with human papillomavirus (HPV) cell entry after binding to host cell surface receptors; however, the mechanism is not fully known. We examined polymorphisms in receptor genes hypothesized to be necessary for HPV cell entry and assessed their associations with clinical progression to precancer.Methods:African American women (N = 1,728) from the MACS/WIHS Combined Cohort Study were included. Two case–control study designs were used—cases with histology-based precancer (CIN3+) and controls without; and cases with cytology-based precancer [high-grade squamous intraepithelial lesions (HSIL)] and controls without. SNPs in candidate genes (SDC1, SDC2, SDC3, SDC4, GPC1, GPC2, GPC3, GPC4, GPC5, GPC6, and ITGA6) were genotyped using an Illumina Omni2.5-quad beadchip. Logistic regression was used to assess the associations in all participants and by HPV genotypes, after adjusting for age, human immunodeficiency virus serostatus, CD4 T cells, and three principal components for ancestry.Results:Minor alleles in SNPs rs77122854 (SDC3), rs73971695, rs79336862 (ITGA6), rs57528020, rs201337456, rs11987725 (SDC2), rs115880588, rs115738853, and rs9301825 (GPC5) were associated with increased odds of both CIN3+ and HSIL, whereas, rs35927186 (GPC5) was found to decrease the odds for both outcomes (P value ≤ 0.01). Among those infected with Alpha-9 HPV types, rs722377 (SDC3), rs16860468, rs2356798 (ITGA6), rs11987725 (SDC2), and rs3848051 (GPC5) were associated with increased odds of both precancer outcomes.Conclusions:Polymorphisms in genes that encode binding receptors for HPV cell entry may play a role in cervical precancer progression.Impact:Our findings are hypothesis generating and support further exploration of mechanisms of HPV entry genes that may help prevent progression to cervical precancer.

16 September 2024
Verified
Other
Open access
AMAmrita Mukherjee
Amrita Mukherjee
YYYuanfan Ye
Yuanfan Ye
HWHoward W. Wiener
Howard W. Wiener
MKMark H. Kuniholm
Mark H. Kuniholm
HMHoward Minkoff
Howard Minkoff
SSSadeep Shrestha
Sadeep Shrestha
Background: Cervical cancer oncogenesis starts with human papillomavirus (HPV) cell entry after binding to host cell surface receptors; however, the mechanism is not fully known. We examined polymorphisms in receptor genes hypothesized to be necessary for HPV cell entry and assessed their associations with clinical progression to pre-cancer. Methods: African-American women (N=1728) from the MACS/WIHS Combined Cohort Study were included. Two case-control study designs were used - cases with histology-based pre-cancer (CIN3+) and controls without; and cases with cytology-based pre-cancer (HSIL) and controls without. Single nucleotide polymorphisms (SNPs) in candidate genes (SDC1, SDC2, SDC3, SDC4, GPC1, GPC2, GPC3, GPC4, GPC5, GPC6 and ITGA6) were genotyped using an Illumina Omni2.5-quad beadchip. Logistic regression was used to assess the associations in all participants and by HPV genotypes, after adjusting for age, HIV-serostatus, CD4 T-cells, and three principal components for ancestry. Results: Minor alleles in SNPs rs77122854 (SDC3), rs73971695, rs79336862 (ITGA6), rs57528020, rs201337456, rs11987725 (SDC2), rs115880588, rs115738853 and rs9301825 (GPC5) were associated with increased odds of both CIN3+ and HSIL, whereas, rs35927186 (GPC5) was found to decrease the odds for both outcomes (p-value≤0.01). Among those infected with Alpha-9 HPV types, rs722377 (SDC3), rs16860468, rs2356798 (ITGA6), rs11987725 (SDC2), and rs3848051 (GPC5) were associated with increased odds of both pre-cancer outcomes. Conclusions: Polymorphisms in genes that encode binding receptors for HPV cell entry may play a role in cervical pre-cancer progression. Impact: Our findings are hypothesis generating and support further exploration of mechanisms of HPV entry genes that may help prevent progression to cervical pre-cancer.

16 September 2024
Verified
Other
Open access
AMAmrita Mukherjee
Amrita Mukherjee
YYYuanfan Ye
Yuanfan Ye
HWHoward W. Wiener
Howard W. Wiener
MKMark H. Kuniholm
Mark H. Kuniholm
HMHoward Minkoff
Howard Minkoff
SSSadeep Shrestha
Sadeep Shrestha
Supplementary Table S1 lists all genetic variants (SNPs) in the candidate genese associated with pre-cancer.

16 September 2024
Verified
Other
Open access
AMAmrita Mukherjee
Amrita Mukherjee
YYYuanfan Ye
Yuanfan Ye
HWHoward W. Wiener
Howard W. Wiener
MKMark H. Kuniholm
Mark H. Kuniholm
HMHoward Minkoff
Howard Minkoff
SSSadeep Shrestha
Sadeep Shrestha
Supplementary Table S1 lists all genetic variants (SNPs) in the candidate genese associated with pre-cancer.